Pharmafile Logo
Pharmafocus logo
Advanced Search

73% of India’s doctors oppose prescribing generics over branded versions

May 9, 2017
Manufacturing and Production, Sales and Marketing India, generics

Following a recent push by Indian Prime Minister Narendra Modi for doctors in the country to prescribe generic drugs over …

News
eef

The Manufacturer’s Organisation calls for robust industrial strategy with new manifesto

May 9, 2017
Manufacturing and Production EFF, The Manufacter's Organisaion

With the 8 June general election only a month away, the EEF – The Manufacturer’s Organisation – has become the …

News
pills-384846_960_720

£6 million statin study to determine potential therapeutic use in MS

May 9, 2017
Manufacturing and Production, Research and Development multiple sclerosis, statins

A large study will take place in the UK to determine whether statins, commonly prescribed to combat “bad cholesterol”, are …

News

Pricing Consultant Job Profile and Description

May 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

About Global Pricing Innovations (GPI)

Appointment

Head of Product Innovation Job Profile and Description

May 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

About Global Pricing Innovations (GPI)

Appointment
happy_doctor

Patient reported outcomes: Putting the patient first

May 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

With clinical practice marching towards a more precision-oriented methodology, assessment of treatment efficacy is undergoing a transformation. Matt Fellows explores the …

Feature
teva_copy

Teva and Active Biotech hit by Phase 3 drug failure

May 8, 2017
Research and Development, Sales and Marketing Active Biotech, Teva

Teva and Active Biotech have been collaborating on the drug laquinimod since 2004 but it now looks like the work put …

News
scale-403585_960_720

Weight loss pill treatment rejected by NICE

May 8, 2017
Medical Communications, Sales and Marketing NICE, orexigen

NICE has announced, in an Appraisal Consultation Document, that it is not able to recommend Orexigen’s Mysimba as a weight …

News
office-space-1988480_960_720

Board battle scuppers Seattle Genetics’ $2 billion licensing deal

May 8, 2017
Sales and Marketing Immunomedics, Seattle Genetics, venBio

In another example of the influence that activist investors can have on the direction of a business, the potentially $2 …

News

NHS staff feeling the pay squeeze, reports NHS Providers

May 8, 2017
Medical Communications, Sales and Marketing NHS, NHS Providers

NHS Providers, the membership organisation and trade association for the NHS, has laid a stark warning at the door of …

News

FDA approves first new treatment for ALS in two decades

May 8, 2017
Sales and Marketing MLS, Mitsubishi Tanabe Pharma America, Radicava

The FDA has approved only the second form of treatment for amyotrophic lateral sclerosis (ALS), with the previous drug, riluzole, …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

May 5, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and today marks the press date of the latest edition of Pharmafile, our bi-annual life sciences market …

News

Pfizer offers breast cancer drug for free following NICE rejection

May 5, 2017
Medical Communications, Sales and Marketing NICE, Pfizer

Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …

News
exit-1722888_960_720

Regulus CEO heads to exit as company struggles with FDA hold

May 5, 2017
Medical Communications, Research and Development Regulus, hepatitis C

Regulus seemed to be in a good place just last year as its lead drug candidate performed well in a …

News
talc_mine

J&J chalks up another defeat in $110 million talc-cancer case

May 5, 2017
Medical Communications Johnson & Johnson, baby powder

Johnson & Johnson has suffered another defeat in a lawsuit against its talcum powder product. The latest case stands as …

News
gsk_hq_logo

GSK boosts Benlysta production with $139 million investment

May 5, 2017
Manufacturing and Production, Medical Communications GSK

GSK has announced that it will invest $139 million into increasing production capacity at its Rockville, Maryland, site. The manufacturing …

News
running-573762_960_720

‘Exercise pill’ boosts endurance by 70% in mice

May 4, 2017
Research and Development

A study by the Salk Institute found that mice that were given a chemical compound, named GW1517 (GW), were able …

News
european_commission_web

European Commission warns UK over drug authorisation validity due to Brexit

May 4, 2017
Medical Communications, Sales and Marketing EMA, European Commission, brexit

The European Commission has issued a warning to pharmaceutical firms in the UK over the validity of current and future …

News
world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017
Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …

News
roche

Roche denies its acne treatment led to suicide of 21 year old

May 4, 2017
Medical Communications, Sales and Marketing Roaccutane, Roche

Last month, Luke Reeves took his own life at the age of just 21. Prior to his death, he had …

News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026